Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 342

1.

Usefulness of an index score as a predictor of hepatic fibrosis in obese patients undergoing bariatric surgery.

Rodríguez RD, Pomar MD, Fernández AC, de Francisco TG, Goñi JL.

Rev Esp Enferm Dig. 2009 Aug;101(8):528-35. English, Spanish.

2.

Evaluation of the nonalcoholic fat liver disease fibrosis score for patients undergoing bariatric surgery.

Pimentel SK, Strobel R, Gonçalves CG, Sakamoto DG, Ivano FH, Coelho JC.

Arq Gastroenterol. 2010 Apr-Jun;47(2):170-3.

3.

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.

Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R, Pigeyre M, Verkindt H, Dharancy S, Louvet A, Romon M, Pattou F.

Gastroenterology. 2009 Aug;137(2):532-40. doi: 10.1053/j.gastro.2009.04.052. Epub 2009 May 4.

PMID:
19409898
4.

Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.

Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.

Obes Surg. 2006 Dec;16(12):1584-93.

PMID:
17217634
5.

The utility of the "NAFLD fibrosis score" in morbidly obese subjects with NAFLD.

Qureshi K, Clements RH, Abrams GA.

Obes Surg. 2008 Mar;18(3):264-70. doi: 10.1007/s11695-007-9295-8. Epub 2008 Jan 24.

PMID:
18214632
6.

The incapacity of the surgeon to identify NASH in bariatric surgery makes biopsy mandatory.

Teixeira AR, Bellodi-Privato M, Carvalheira JB, Pilla VF, Pareja JC, D'Albuquerque LA.

Obes Surg. 2009 Dec;19(12):1678-84. doi: 10.1007/s11695-009-9980-x.

PMID:
19789933
7.

The comparison of scoring scales for liver biopsy assessment in morbidly obese patients undergoing bariatric surgery.

Ziolkowski A, Wylezol M, Kukla M, Zwirska-Korczala K, Berdowska A, Pardela M, Gabriel A.

Obes Surg. 2005 Oct;15(9):1309-14.

PMID:
16259893
8.

Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?

Helling TS, Helzberg JH, Nachnani JS, Gurram K.

Surg Obes Relat Dis. 2008 Sep-Oct;4(5):612-7. doi: 10.1016/j.soard.2007.11.007. Epub 2008 Jan 28.

PMID:
18226970
9.

Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.

Beymer C, Kowdley KV, Larson A, Edmonson P, Dellinger EP, Flum DR.

Arch Surg. 2003 Nov;138(11):1240-4.

PMID:
14609874
10.

Hepatic histology in obese patients undergoing bariatric surgery.

Machado M, Marques-Vidal P, Cortez-Pinto H.

J Hepatol. 2006 Oct;45(4):600-6. Epub 2006 Jul 25.

PMID:
16899321
11.

Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.

Furuya CK Jr, de Oliveira CP, de Mello ES, Faintuch J, Raskovski A, Matsuda M, Vezozzo DC, Halpern A, Garrido AB Jr, Alves VA, Carrilho FJ.

J Gastroenterol Hepatol. 2007 Apr;22(4):510-4.

PMID:
17376042
12.

Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.

Larson SP, Bowers SP, Palekar NA, Ward JA, Pulcini JP, Harrison SA.

Clin Gastroenterol Hepatol. 2007 Nov;5(11):1329-32. Epub 2007 Aug 16.

PMID:
17702661
13.

[Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].

Chavarría-Arciniega S, López-Alvarenga JC, Uribe-Uribe NO, Herrera-Hernández M, González-Barranco J.

Rev Invest Clin. 2005 Jul-Aug;57(4):505-12. Spanish.

PMID:
16315634
14.

High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.

Sabaté JM, Jouët P, Harnois F, Mechler C, Msika S, Grossin M, Coffin B.

Obes Surg. 2008 Apr;18(4):371-7. doi: 10.1007/s11695-007-9398-2. Epub 2008 Feb 20.

PMID:
18286348
15.

A comparison of wedge and needle hepatic biopsy in open bariatric surgery.

Padoin AV, Mottin CC, Moretto M, Berleze D, Kupski C, Glock L, Reichel CL, da Silva VD, da Silva JB.

Obes Surg. 2006 Feb;16(2):178-82.

PMID:
16469220
16.

Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies.

Papadia FS, Marinari GM, Camerini G, Murelli F, Carlini F, Stabilini C, Scopinaro N.

Obes Surg. 2004 Aug;14(7):952-8.

PMID:
15329185
17.

Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.

Weiner RA.

Dig Dis. 2010;28(1):274-9. doi: 10.1159/000282102. Epub 2010 May 7.

PMID:
20460923
18.

Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery.

Mottin CC, Moretto M, Padoin AV, Kupski C, Swarowsky AM, Glock L, Duval V, da Silva JB.

Obes Surg. 2005 Jun-Jul;15(6):788-93.

PMID:
15978148
19.

Review article: Non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery.

De Ridder RJ, Schoon EJ, Smulders JF, van Hout GC, Stockbrügger RW, Koek GH.

Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:195-201. doi: 10.1111/j.1365-2036.2007.03483.x. Review.

20.

Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery.

Trak-Smayra V, Dargere D, Noun R, Albuquerque M, Yaghi C, Gannagé-Yared MH, Bedossa P, Paradis V.

Gut. 2009 Jun;58(6):825-32. doi: 10.1136/gut.2007.140087. Epub 2008 Apr 10.

PMID:
18403495

Supplemental Content

Support Center